Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 5 studies | 24% ± 8% | |
pericyte | 5 studies | 21% ± 5% | |
retinal ganglion cell | 3 studies | 55% ± 17% |
Insufficient scRNA-seq data for expression of RBPMS2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 77% | 2308.35 | 189 / 245 | 97% | 21.70 | 488 / 502 |
thymus | 59% | 974.61 | 388 / 653 | 96% | 21.76 | 579 / 605 |
uterus | 95% | 3652.26 | 161 / 170 | 56% | 12.75 | 259 / 459 |
kidney | 51% | 898.79 | 45 / 89 | 89% | 20.44 | 800 / 901 |
bladder | 86% | 7908.71 | 18 / 21 | 49% | 8.89 | 249 / 504 |
esophagus | 68% | 6427.36 | 981 / 1445 | 57% | 10.57 | 104 / 183 |
stomach | 63% | 3752.24 | 226 / 359 | 50% | 13.57 | 143 / 286 |
intestine | 75% | 7562.22 | 726 / 966 | 31% | 5.20 | 166 / 527 |
breast | 42% | 722.77 | 192 / 459 | 61% | 5.58 | 677 / 1118 |
ovary | 28% | 449.69 | 50 / 180 | 72% | 9.90 | 308 / 430 |
eye | 0% | 0 | 0 / 0 | 98% | 31.40 | 78 / 80 |
heart | 97% | 15119.70 | 835 / 861 | 0% | 0 | 0 / 0 |
liver | 9% | 133.52 | 20 / 226 | 87% | 17.13 | 354 / 406 |
adipose | 76% | 1375.48 | 912 / 1204 | 0% | 0 | 0 / 0 |
skin | 2% | 23.87 | 30 / 1809 | 68% | 18.25 | 322 / 472 |
brain | 0% | 4.17 | 6 / 2642 | 66% | 5.82 | 463 / 705 |
blood vessel | 66% | 6083.05 | 877 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 63% | 7.51 | 112 / 178 |
adrenal gland | 1% | 9.42 | 2 / 258 | 59% | 9.10 | 135 / 230 |
lung | 8% | 124.71 | 46 / 578 | 48% | 8.88 | 554 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 9% | 1.04 | 4 / 45 |
peripheral blood | 6% | 142.39 | 58 / 929 | 0% | 0 | 0 / 0 |
spleen | 2% | 24.02 | 4 / 241 | 0% | 0 | 0 / 0 |
muscle | 1% | 20.54 | 12 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048661 | Biological process | positive regulation of smooth muscle cell proliferation |
GO_0030514 | Biological process | negative regulation of BMP signaling pathway |
GO_0048557 | Biological process | embryonic digestive tract morphogenesis |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0051151 | Biological process | negative regulation of smooth muscle cell differentiation |
GO_0005829 | Cellular component | cytosol |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
GO_0003729 | Molecular function | mRNA binding |
Gene name | RBPMS2 |
Protein name | RNA-binding protein with multiple splicing 2 (RNA binding protein, mRNA processing factor 2) |
Synonyms | |
Description | FUNCTION: RNA-binding protein involved in the regulation of smooth muscle cell differentiation and proliferation in the gastrointestinal system . Binds NOG mRNA, the major inhibitor of the bone morphogenetic protein (BMP) pathway. Mediates an increase of NOG mRNA levels, thereby contributing to the negative regulation of BMP signaling pathway and promoting reversible dedifferentiation and proliferation of smooth muscle cells (By similarity). Acts as a pre-mRNA alternative splicing regulator (By similarity). Mediates ACTN1 and FLNB alternative splicing (By similarity). Likely binds to mRNA tandem CAC trinucleotide or CA dinucleotide motifs . . |
Accessions | ENST00000560606.5 [Q6ZRY4-2] Q6ZRY4 ENST00000300069.5 [Q6ZRY4-1] |